EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | chr7:102440961-102441508:+ | ENST00000488996.1 | ENSG00000160991.14 | ORAI2 | ncRNA_intronic | AluSx1,AluSx | chr7:102440961-102441508:+.alignment |
chr7:102448458-102455172:+ | ENST00000356387.5 | ENSG00000160991.14 | ORAI2 | UTR3 | AluSp,AluSx1,(TTTGT)n,AluSz,AluSg,AluSq2,AluJr,(TTCTCG)n,AluJo,AluSx | chr7:102448458-102455172:+.alignment |
chr7:102448458-102455172:+ | ENST00000403646.6 | ENSG00000160991.14 | ORAI2 | UTR3 | AluSp,AluSx1,(TTTGT)n,AluSz,AluSg,AluSq2,AluJr,(TTCTCG)n,AluJo,AluSx | chr7:102448458-102455172:+.alignment |
chr7:102448458-102455172:+ | ENST00000473939.1 | ENSG00000160991.14 | ORAI2 | UTR3 | AluSp,AluSx1,(TTTGT)n,AluSz,AluSg,AluSq2,AluJr,(TTCTCG)n,AluJo,AluSx | chr7:102448458-102455172:+.alignment |
chr7:102448458-102455172:+ | ENST00000478730.5 | ENSG00000160991.14 | ORAI2 | UTR3 | AluSp,AluSx1,(TTTGT)n,AluSz,AluSg,AluSq2,AluJr,(TTCTCG)n,AluJo,AluSx | chr7:102448458-102455172:+.alignment |
chr7:102448458-102455172:+ | ENST00000611770.3 | ENSG00000160991.14 | ORAI2 | UTR3 | AluSp,AluSx1,(TTTGT)n,AluSz,AluSg,AluSq2,AluJr,(TTCTCG)n,AluJo,AluSx | chr7:102448458-102455172:+.alignment |
ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
ENSG00000160991.14,ORAI2 | ACC | EAG | T_cells_regulatory_(Tregs) | 2.0847e-02 | 0.4507 | .ENSG00000160991.14,ORAI2.png) |
ENSG00000160991.14,ORAI2 | BLCA | EAG | B_cells_naive | 3.8137e-02 | 0.2338 |  |
chr7:102448458-102455172:+ | BRCA | EER | Mast_cells_activated | 2.7904e-03 | 0.1288 |  |
ENSG00000160991.14,ORAI2 | BRCA | EAG | Mast_cells_activated | 3.0052e-03 | 0.1276 |  |
ENSG00000160991.14,ORAI2 | CESC | EAG | Neutrophils | 2.0546e-02 | 0.3010 |  |
ENSG00000160991.14,ORAI2 | COAD | EAG | Dendritic_cells_activated | 5.7343e-10 | 0.7548 |  |
chr7:102448458-102455172:+ | GBM | EER | Dendritic_cells_resting | 2.7748e-02 | 0.1816 |  |
ENSG00000160991.14,ORAI2 | GBM | EAG | Dendritic_cells_resting | 2.7748e-02 | 0.1816 |  |
ENSG00000160991.14,ORAI2 | HNSC | EAG | Macrophages_M2 | 6.2742e-03 | 0.3283 |  |
ENSG00000160991.14,ORAI2 | KIRC | EAG | Monocytes | 3.3185e-02 | -0.1808 |  |
chr7:102448458-102455172:+ | LAML | EER | Mast_cells_resting | 2.9789e-02 | 0.2231 |  |
ENSG00000160991.14,ORAI2 | LAML | EAG | Mast_cells_resting | 2.9897e-02 | 0.2173 |  |
chr7:102448458-102455172:+ | LGG | EER | Dendritic_cells_activated | 4.4313e-03 | 0.1350 |  |
ENSG00000160991.14,ORAI2 | LGG | EAG | Dendritic_cells_activated | 4.3885e-03 | 0.1351 |  |
chr7:102448458-102455172:+ | LUAD | EER | Macrophages_M0 | 1.9778e-02 | 0.1901 |  |
ENSG00000160991.14,ORAI2 | LUAD | EAG | Macrophages_M2 | 3.4300e-02 | 0.1724 |  |
ENSG00000160991.14,ORAI2 | MESO | EAG | T_cells_CD4_naive | 2.3552e-03 | 0.5426 |  |
chr7:102448458-102455172:+ | OV | EER | Macrophages_M0 | 4.3398e-02 | 0.1294 |  |
ENSG00000160991.14,ORAI2 | OV | EAG | Dendritic_cells_resting | 2.8056e-02 | 0.1401 |  |
ENSG00000160991.14,ORAI2 | PAAD | EAG | T_cells_CD4_naive | 3.8230e-05 | 0.4334 |  |
chr7:102448458-102455172:+ | PCPG | EER | T_cells_CD4_memory_resting | 1.5180e-02 | 0.2758 |  |
ENSG00000160991.14,ORAI2 | PCPG | EAG | T_cells_CD4_memory_resting | 1.5180e-02 | 0.2758 |  |
ENSG00000160991.14,ORAI2 | PRAD | EAG | Dendritic_cells_activated | 5.7604e-11 | 0.4470 |  |
ENSG00000160991.14,ORAI2 | SARC | EAG | Macrophages_M1 | 9.0902e-03 | 0.2096 |  |
chr7:102448458-102455172:+ | SKCM | EER | T_cells_CD4_memory_activated | 4.0159e-02 | -0.1667 |  |
ENSG00000160991.14,ORAI2 | SKCM | EAG | T_cells_CD4_memory_activated | 3.4728e-02 | -0.1708 |  |
chr7:102448458-102455172:+ | STAD | EER | T_cells_CD8 | 2.8878e-02 | 0.1371 |  |
ENSG00000160991.14,ORAI2 | STAD | EAG | T_cells_CD4_memory_resting | 1.7677e-02 | -0.1479 |  |
ENSG00000160991.14,ORAI2 | TGCT | EAG | Dendritic_cells_activated | 2.1773e-02 | 0.4478 |  |
chr7:102448458-102455172:+ | THCA | EER | Macrophages_M1 | 5.8379e-03 | -0.1526 |  |
ENSG00000160991.14,ORAI2 | THCA | EAG | Macrophages_M1 | 6.0426e-03 | -0.1520 |  |
ENSG00000160991.14,ORAI2 | UCS | EAG | Plasma_cells | 1.5568e-03 | 0.5990 |  |
ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
ENSG00000160991.14,ORAI2 | ACC | GSVA_HALLMARK_GLYCOLYSIS | EAG | 3.4580e-03 | -0.5520 |  |
ENSG00000160991.14,ORAI2 | BLCA | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 1.5368e-02 | -0.2719 |  |
ENSG00000160991.14,ORAI2 | BRCA | GSVA_HALLMARK_MYC_TARGETS_V2 | EAG | 5.6964e-03 | 0.1189 |  |
chr7:102448458-102455172:+ | BRCA | GSVA_HALLMARK_MYC_TARGETS_V2 | EER | 8.4729e-03 | 0.1135 |  |
ENSG00000160991.14,ORAI2 | COAD | GSVA_HALLMARK_P53_PATHWAY | EAG | 8.4695e-03 | -0.3759 |  |
ENSG00000160991.14,ORAI2 | GBM | GSVA_HALLMARK_MITOTIC_SPINDLE | EAG | 6.8314e-03 | 0.2222 |  |
chr7:102448458-102455172:+ | GBM | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 6.8314e-03 | 0.2222 |  |
ENSG00000160991.14,ORAI2 | HNSC | GSVA_HALLMARK_NOTCH_SIGNALING | EAG | 6.6237e-03 | -0.3263 |  |
ENSG00000160991.14,ORAI2 | KIRC | GSVA_HALLMARK_IL2_STAT5_SIGNALING | EAG | 2.1319e-02 | -0.1952 |  |
ENSG00000160991.14,ORAI2 | KIRP | GSVA_HALLMARK_DNA_REPAIR | EAG | 1.6638e-03 | -0.2978 |  |
chr7:102448458-102455172:+ | LAML | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 1.1469e-02 | 0.2584 |  |
ENSG00000160991.14,ORAI2 | LAML | GSVA_HALLMARK_HEME_METABOLISM | EAG | 6.6787e-03 | 0.2696 |  |
ENSG00000160991.14,ORAI2 | LGG | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 9.4248e-04 | -0.1566 |  |
chr7:102448458-102455172:+ | LGG | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 9.6589e-04 | -0.1563 |  |
ENSG00000160991.14,ORAI2 | LUAD | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EAG | 1.3280e-02 | -0.2011 |  |
chr7:102448458-102455172:+ | LUAD | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EER | 4.5123e-02 | -0.1639 |  |
ENSG00000160991.14,ORAI2 | MESO | GSVA_HALLMARK_UV_RESPONSE_UP | EAG | 5.9285e-04 | -0.5992 |  |
chr7:102448458-102455172:+ | OV | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 2.2557e-02 | -0.1460 |  |
ENSG00000160991.14,ORAI2 | OV | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EAG | 2.7947e-02 | -0.1402 |  |
ENSG00000160991.14,ORAI2 | PAAD | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EAG | 2.3656e-02 | -0.2467 |  |
chr7:102448458-102455172:+ | PCPG | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 6.8818e-04 | -0.3785 |  |
ENSG00000160991.14,ORAI2 | PCPG | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EAG | 6.8818e-04 | -0.3785 |  |
ENSG00000160991.14,ORAI2 | PRAD | GSVA_HALLMARK_PEROXISOME | EAG | 1.2781e-04 | -0.2709 |  |
ENSG00000160991.14,ORAI2 | SARC | GSVA_HALLMARK_ALLOGRAFT_REJECTION | EAG | 4.5559e-04 | -0.2791 |  |
ENSG00000160991.14,ORAI2 | SKCM | GSVA_HALLMARK_HEME_METABOLISM | EAG | 7.4244e-04 | -0.2699 |  |
chr7:102448458-102455172:+ | SKCM | GSVA_HALLMARK_HEME_METABOLISM | EER | 5.6927e-04 | -0.2763 |  |
chr7:102448458-102455172:+ | STAD | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EER | 4.9808e-02 | -0.1232 |  |
ENSG00000160991.14,ORAI2 | STAD | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EAG | 5.2619e-03 | -0.1736 |  |
chr7:102448458-102455172:+ | THCA | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EER | 2.5387e-06 | -0.2576 |  |
ENSG00000160991.14,ORAI2 | THCA | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EAG | 2.6296e-06 | -0.2572 |  |
ENSG00000160991.14,ORAI2 | THYM | GSVA_HALLMARK_ADIPOGENESIS | EAG | 2.8662e-04 | -0.4669 |  |
ENSG00000160991.14,ORAI2 | UCEC | GSVA_HALLMARK_CHOLESTEROL_HOMEOSTASIS | EAG | 2.6945e-02 | -0.2626 |  |
ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
ENSG00000160991.14,ORAI2 | ACC | Elesclomol | EAG | 7.6553e-03 | -0.5109 |  |
ENSG00000160991.14,ORAI2 | BLCA | CI.1040 | EAG | 5.4146e-03 | 0.3101 |  |
ENSG00000160991.14,ORAI2 | BRCA | Methotrexate | EAG | 1.9076e-04 | -0.1600 |  |
chr7:102448458-102455172:+ | BRCA | Methotrexate | EER | 2.1599e-04 | -0.1590 |  |
ENSG00000160991.14,ORAI2 | CESC | BI.2536 | EAG | 2.3791e-02 | -0.2940 |  |
ENSG00000160991.14,ORAI2 | COAD | AZ628 | EAG | 1.1765e-03 | 0.4544 |  |
ENSG00000160991.14,ORAI2 | GBM | Embelin | EAG | 2.4473e-03 | -0.2481 |  |
chr7:102448458-102455172:+ | GBM | Embelin | EER | 2.4473e-03 | -0.2481 |  |
ENSG00000160991.14,ORAI2 | HNSC | Bleomycin | EAG | 7.1134e-03 | -0.3236 |  |
ENSG00000160991.14,ORAI2 | KIRP | Erlotinib | EAG | 1.3737e-02 | 0.2354 |  |
ENSG00000160991.14,ORAI2 | LAML | BI.D1870 | EAG | 2.4730e-03 | -0.2994 |  |
chr7:102448458-102455172:+ | LAML | Imatinib | EER | 2.5687e-02 | -0.2289 |  |
ENSG00000160991.14,ORAI2 | LGG | FTI.277 | EAG | 1.1040e-05 | -0.2072 |  |
chr7:102448458-102455172:+ | LGG | FTI.277 | EER | 1.1443e-05 | -0.2068 |  |
ENSG00000160991.14,ORAI2 | LUAD | Imatinib | EAG | 3.0956e-03 | -0.2392 |  |
chr7:102448458-102455172:+ | LUAD | Imatinib | EER | 5.4407e-04 | -0.2790 |  |
ENSG00000160991.14,ORAI2 | MESO | Gefitinib | EAG | 3.9649e-02 | -0.3842 |  |
chr7:102448458-102455172:+ | OV | Erlotinib | EER | 1.3476e-02 | 0.1580 |  |
ENSG00000160991.14,ORAI2 | OV | AKT.inhibitor.VIII | EAG | 2.4893e-02 | -0.1430 |  |
ENSG00000160991.14,ORAI2 | PAAD | CCT007093 | EAG | 1.4101e-02 | 0.2670 |  |
chr7:102448458-102455172:+ | PCPG | BI.D1870 | EER | 2.1282e-02 | -0.2621 |  |
ENSG00000160991.14,ORAI2 | PCPG | BI.D1870 | EAG | 2.1282e-02 | -0.2621 |  |
ENSG00000160991.14,ORAI2 | PRAD | Lenalidomide | EAG | 5.0352e-07 | -0.3506 |  |
ENSG00000160991.14,ORAI2 | SARC | CI.1040 | EAG | 6.6561e-05 | 0.3157 |  |
chr7:102448458-102455172:+ | SKCM | Docetaxel | EER | 1.1454e-02 | -0.2046 |  |
ENSG00000160991.14,ORAI2 | SKCM | Docetaxel | EAG | 1.1361e-02 | -0.2042 |  |
ENSG00000160991.14,ORAI2 | STAD | AS601245 | EAG | 1.8054e-03 | 0.1938 |  |
chr7:102448458-102455172:+ | STAD | AS601245 | EER | 4.2498e-03 | 0.1788 |  |
ENSG00000160991.14,ORAI2 | TGCT | Epothilone.B | EAG | 3.3959e-03 | -0.5529 |  |
chr7:102448458-102455172:+ | THCA | KU.55933 | EER | 3.4340e-05 | 0.2280 |  |
ENSG00000160991.14,ORAI2 | THCA | KU.55933 | EAG | 3.3682e-05 | 0.2282 |  |
ENSG00000160991.14,ORAI2 | THYM | GW.441756 | EAG | 1.4075e-03 | 0.4165 |  |
ENSG00000160991.14,ORAI2 | UCEC | A.443654 | EAG | 2.7942e-02 | 0.2610 |  |
ENSG00000160991.14,ORAI2 | UCS | ABT.263 | EAG | 7.7041e-04 | -0.6283 |  |